Myriad Genetic Laboratories, Inc. is a global biopharmaceutical company focused on the development and marketing of novel molecular diagnostic products. Myriad develops and markets predictive and pharmacogenetic testing products including a variety of tests that can predict an individual's risk for developing specific types of hereditary cancer, as well as a diagnostic test that can assess a cancer patient's risk of developing toxicity to 5-fluorouracil (5-FU)–based chemotherapeutics.
Myriad Genetic Laboratories, Inc.
320 Wakara Way
Salt Lake City, UT 84108
For more information about Myriad, please visit www.myriad.com.
